Skip to main content
. 2015 Jun 10;35(11):1703–1710. doi: 10.1038/jcbfm.2015.139

Table 2. Mean global cerebral blood flow in mL/100 g per minute (95% confidence intervals), test–retest variability, and mean difference to positron emission tomography arterial input function.

    Baseline
Acetazolamide
CBF method Injected activity (MBq) CBF 95% CI (mL/100g per minute) Testretest (%) ΔPET AIF (%) CBF 95% CI (mL/100g per minute) Testretest (%) ΔPET AIF (%)
PET AIF 100 27.6 (24.0; 31.7) 7.7   64.4 (55.3; 74.9) 9.8  
  20 27.4 (23.5; 32.1) 5.7   64.0 (55.0; 74.5) 8.9  
ASL 100 29.5 (23.7; 36.7) 8.6 2.3 76.8 (60.9; 96.8) 8.2 19.3a
  20 24.7 (19.0; 32.1) 18.8b −11.3 80.7 (63.7; 102.2) 11.7 27.3a
PET IDIF 100 33.6 (29.6; 38.1) 5.9 21.8a 78.6 (69.5; 88.9) 9.0 22.1a
  20 34.0 (29.9; 38.8) 12.4 22.1a 73.7 (64.1; 84.7) 10.7 15.1a

AIF, arterial input function; ASL, arterial spin labeling; CI; confidence interval; IDIF, image-derived input function; PET, positron emission tomography.

Global CBF values from seven healthy newborn piglets calculated as geometric means. Cerebral blood flow is given in mL/100 g per minute. Test–retest: absolute variability. ΔPET AIF: relative difference to PET AIF CBF. Missing values: one in PET AIF, six in ASL (four in baseline 100 MBq scans).

a

Significant difference (P<0.05) between methods by mixed linear model test.

b

Excluding an outlier gives test–retest 11.9% for 20 MBq scans.